Shares of USANA Health Sciences, Inc. (NYSE:USNA) fell 5% during trading on Friday . The stock traded as low as $75.40 and last traded at $75.53. 500,624 shares changed hands during mid-day trading, an increase of 144% from the average session volume of 204,974 shares. The stock had previously closed at $79.54.
Several equities research analysts recently weighed in on USNA shares. Pivotal Research reissued a “buy” rating and set a $105.00 price target on shares of USANA Health Sciences in a research report on Wednesday, May 1st. Tigress Financial started coverage on shares of USANA Health Sciences in a research report on Tuesday, April 16th. They set a “buy” rating for the company.
The stock has a market cap of $1.86 billion, a price-to-earnings ratio of 14.64 and a beta of 0.30.
USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, April 30th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.02. USANA Health Sciences had a net margin of 10.38% and a return on equity of 29.51%. The business had revenue of $272.90 million during the quarter, compared to the consensus estimate of $272.20 million. During the same quarter in the previous year, the firm posted $1.19 EPS. The firm’s revenue was down 6.5% on a year-over-year basis. As a group, equities research analysts predict that USANA Health Sciences, Inc. will post 5.18 EPS for the current year.
A number of large investors have recently bought and sold shares of USNA. Royce & Associates LP grew its position in USANA Health Sciences by 66.4% in the 1st quarter. Royce & Associates LP now owns 381 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. NumerixS Investment Technologies Inc bought a new stake in USANA Health Sciences in the 4th quarter worth approximately $34,000. Flagship Harbor Advisors LLC grew its position in USANA Health Sciences by 60.8% in the 4th quarter. Flagship Harbor Advisors LLC now owns 677 shares of the company’s stock worth $79,000 after purchasing an additional 256 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in USANA Health Sciences by 23.8% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 858 shares of the company’s stock worth $101,000 after purchasing an additional 165 shares during the period. Finally, Great West Life Assurance Co. Can grew its position in USANA Health Sciences by 43.8% in the 4th quarter. Great West Life Assurance Co. Can now owns 1,516 shares of the company’s stock worth $172,000 after purchasing an additional 462 shares during the period. 54.16% of the stock is owned by institutional investors and hedge funds.
About USANA Health Sciences (NYSE:USNA)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Further Reading: Calculate Your Return on Investment (ROI)
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.